Toll‐like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators

GLIA - Tập 53 Số 7 - Trang 688-695 - 2006
Malika Bsibsi1, C. Persoon-Deen1, R.W.H. Verwer2, Sonja Meeuwsen1, Rivka Ravid3, Johannes M. van Noort1
1Division of Biomedical Research, TNO Quality of Life, Leiden, The Netherlands.
2Netherlands Institute for Brain Research, Amsterdam, The Netherlands
3Netherlands Brain Bank, Amsterdam, The Netherlands

Tóm tắt

Abstract

Toll‐like receptors (TLRs) are innate immunity receptors that are expressed on a wide range of cell types, including CNS glial cells. In general, TLR engagement by specific sets of microbial ligands triggers production of pro‐inflammatory factors and enhances antigen‐presenting cell functions. The functional roles of TLR in the CNS, however, are still poorly understood. While adult human astrocytes in culture dominantly express TLR4, they display a strikingly strong and selective induction of TLR3 when activated by pro‐inflammatory cytokines, TLR3 or TLR4 agonists, or oxidative stress. Gene profiling analysis of the astrocyte response to either TLR3 or TLR4 activation revealed that TLR3, but not TLR4, induces expression of a range of neuroprotective mediators and several other molecules that regulate cellular growth, differentiation, and migration. Also, TLR3 triggered enhanced production of anti‐inflammatory cytokines including interleukin‐9 (IL‐9), IL‐10, and IL‐11 and downregulation of the p40 subunit of IL‐12 and IL‐23. The collective TLR3‐induced products were found in functional assays to inhibit astrocyte growth, promote human endothelial cell growth, and importantly, to enhance neuronal survival in organotypic human brain slice cultures. Together, our data indicate that TLR3 is induced on human astrocytes upon inflammation and when activated, mediates a comprehensive neuroprotective response rather than a polarized pro‐inflammatory reaction. © 2006 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

10.1038/90609

10.1038/35099560

10.1016/S0166-2236(99)01453-8

10.1189/jlb.68.1.1

10.1086/426399

10.1002/glia.10256

10.1002/1096-9861(20000918)425:2<315::AID-CNE12>3.0.CO;2-#

10.1093/jnen/61.11.1013

10.1074/jbc.M305835200

Dijkhuizen PA, 2005, Regulation of dendritic growth by calcium and neurotrophin signaling, Prog Brain Res, 147, 17

10.1016/S1074-7613(02)00390-4

10.4049/jimmunol.170.7.3565

10.4049/jimmunol.164.6.3207

10.1016/j.jneuroim.2004.09.009

10.1093/emboj/18.19.5159

10.4049/jimmunol.164.8.4197

10.4049/jimmunol.175.7.4320

10.1074/jbc.M310175200

10.1016/j.neuint.2004.07.001

10.1038/nm0602-620

10.4049/jimmunol.171.6.3154

10.1002/glia.10259

10.1038/nri702

10.1038/ni886

10.1002/path.1645

10.1038/35049004

10.1074/jbc.274.49.35053

10.1002/glia.20234

10.1523/JNEUROSCI.22-21-09221.2002

Strle K, 2001, Interleukin‐10 in the brain, Crit Rev Immunol, 2, 427

10.1146/annurev.immunol.21.120601.141126

10.1016/j.cardiores.2004.12.002

10.1002/jnr.20001

10.1016/S1471-4906(02)02259-7

Trepicchio WL, 1997, IL‐11 regulates macrophage effector function through the inhibition of nuclear factor‐kappaB, J Immunol, 159, 5661, 10.4049/jimmunol.159.11.5661

10.1096/fj.01-0504com